Table 1.
Mean and Standard Deviations of NFkb, Caspase-3, ALT and MDA Examination in 11 Groups of SD Rats
| Group | NFkb (ng/mL) | Caspase 3 (ng/mL) | ALT (IU/L) | MDA (mmol/mL) |
|---|---|---|---|---|
| C1 | 32.85 ±3.97 | 1.60 ±0.07 | 17.96 ±0.31 | 0.68 ±0.18 |
| C2 | 632.98 ±9.96 | 11.74 ±0.47 | 55.43 ±1.72 | 10.10 ±0.38 |
| T1.1 | 153.91 ±6.39 | 6.89 ±0.16 | 27.27 ±1.20 | 5.16 ±0.28 |
| T1.2 | 122.43 ±4.51 | 4.16 ±0.38 | 23.06 ±0.51 | 3.63 ±0.18 |
| T1.3 | 67.09 ±9.46 | 2.57 ±0.14 | 20.07 ±0.50 | 2.58 ±0.18 |
| T2.1 | 120.48 ±5.46 | 6.39 ±0.13 | 27.11 ±0.57 | 3.57 ±0.43 |
| T2.2 | 74.23 ±9.47 | 3.78 ±0.29 | 20.47 ±0.57 | 2.56 ±0.23 |
| T2.3 | 63.19 ±2.81 | 1.94 ±0.08 | 19.26 ±0.59 | 1.90 ±0.09 |
| T3.1 | 203.90 ±7.18 | 7.11 ±0.22 | 32.13 ±1.04 | 5.59 ±0.24 |
| T3.2 | 141.25 ±5.03 | 4.99 ±0.13 | 25.81 ±1.28 | 4.10 ±0.17 |
| T3.3 | 132.00 ±4.58 | 3.00 ±0.08 | 24.84 ±1.08 | 3.05 ±0.14 |
| p-value | <0.001** | <0.001** | <0.001** | <0.001** |
C1= Normal control; C2 = control negative (Cisplatin 5 mg/kgBW); T1.1 = Cisplatin 5 mg/kgBW + M.oleifera 300 mg/kgBW; T1.2 = Cisplatin 5 mg/kgBW + M.oleifera 600 mg/kgBW; T1.3 = Cisplatin 5 mg/kgBW + M.oleifera 1200 mg/kgBW; T2.1 = M.oleifera 300 mg/kgBW → Cisplatin 5 mg/kgBW → M.oleifera 300 mg/kgBW; T2.2= M.oleifera 600 mg/kgBW → Cisplatin 5 mg/kgBW → M.oleifera 600 mg/kgBW; T2.3= M.oleifera 1200 mg/kgBW → Cisplatin 5 mg/kgBW → M.oelifera 1200 mg/kgBW; T3.1= Cisplatin 5 mg/kgBW → M.oleifera 300 mg/kgBW; T3.2 = Cisplatin 5 mg/kgBW → M.oleifera 600 mg/kgBW; T3.3 = Cisplatin 5 mg/kgBW → M.oleifera 1200 mg/kgBW; Brown-Forsythe test (if the data was normally distributed but not homegen); * Significant if p<0.05; ** Significant if p<0.01